{"id":6627,"date":"2017-05-01T14:21:00","date_gmt":"2017-05-01T14:21:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=6627"},"modified":"2022-01-28T14:27:47","modified_gmt":"2022-01-28T14:27:47","slug":"granulocitoaferesis-en-2017-puesta-al-dia-spanish","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/","title":{"rendered":"Granulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish)"},"content":{"rendered":"
\n

Cabriada, J.L.<\/a>,\u00a0Rodr\u00edguez-La<\/a><\/em>go, I.<\/a><\/p>\n<\/div>\n\n

\n

Enfermedad Inflamatoria Intestinal 20017 (16) 2,<\/a> 62-69 DOI:\u00a010.1016\/j.eii.2016.12.001<\/a>\u00a0<\/p>\n<\/div>\n\n

\n

Granulocyte apheresis is a procedure that allows the removal of different activated leukocyte populations and it also modifies some circulating inflammatory mediators. These effects, along with its immunomodulatory potential, make it an attractive therapeutic option in inflammatory bowel disease. Previous studies with this technique have had significant limitations, but recent data is emerging about the ideal clinical setting in which granulocyte apheresis should be indicated. Most of the evidence supports its use in conditions that are dependent or refractory to corticosteroids, especially when treatments with immunomodulators or biologics has failed and when it is necessary to reduce or avoid the use of systemic corticosteroids. Its excellent safety profile gives it a role in cases of comorbidity or risk in the use of immunosuppressive drugs or in paediatric patients. In this review, we provide an update on the role of granulocyte apheresis in inflammatory bowel disease.<\/p>\n<\/div>\n\n

\n

https:\/\/www.elsevier.es\/es-revista-enfermedad-inflamatoria-intestinal-al-dia-220-articulo-granulocitoaferesis-2017-puesta-al-dia-S1696780116300999<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Cabriada, J.L.,\u00a0Rodr\u00edguez-Lago, I. Enfermedad Inflamatoria Intestinal 20017 (16) 2, 62-69 DOI:\u00a010.1016\/j.eii.2016.12.001\u00a0 Granulocyte apheresis is a procedure that allows the removal of different activated leukocyte populations and it also modifies some circulating inflammatory mediators. These effects, along with its immunomodulatory potential, make it an attractive therapeutic option in inflammatory bowel disease. Previous studies with this technique […]<\/p>\n","protected":false},"template":"","scientific_tags":[303,440,159,424,426,74,173,405,156,55,135,306],"class_list":["post-6627","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-combination","scientific_tags-comorbidity","scientific_tags-crohns-disease","scientific_tags-gma","scientific_tags-ibd","scientific_tags-leukocytapheresis","scientific_tags-moa","scientific_tags-pediatric","scientific_tags-safety","scientific_tags-steroid-dependent","scientific_tags-steroid-refractory","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"\nGranulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish) - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish) - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Cabriada, J.L.,\u00a0Rodr\u00edguez-Lago, I. Enfermedad Inflamatoria Intestinal 20017 (16) 2, 62-69 DOI:\u00a010.1016\/j.eii.2016.12.001\u00a0 Granulocyte apheresis is a procedure that allows the removal of different activated leukocyte populations and it also modifies some circulating inflammatory mediators. These effects, along with its immunomodulatory potential, make it an attractive therapeutic option in inflammatory bowel disease. Previous studies with this technique […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-28T14:27:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/\",\"name\":\"Granulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish) - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2017-05-01T14:21:00+00:00\",\"dateModified\":\"2022-01-28T14:27:47+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish) - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/","og_locale":"fr_FR","og_type":"article","og_title":"Granulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish) - Adacyte","og_description":"Cabriada, J.L.,\u00a0Rodr\u00edguez-Lago, I. Enfermedad Inflamatoria Intestinal 20017 (16) 2, 62-69 DOI:\u00a010.1016\/j.eii.2016.12.001\u00a0 Granulocyte apheresis is a procedure that allows the removal of different activated leukocyte populations and it also modifies some circulating inflammatory mediators. These effects, along with its immunomodulatory potential, make it an attractive therapeutic option in inflammatory bowel disease. Previous studies with this technique […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/","og_site_name":"Adacyte","article_modified_time":"2022-01-28T14:27:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/","name":"Granulocitoaf\u00e9resis en 2017. Puesta al d\u00eda (Spanish) - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2017-05-01T14:21:00+00:00","dateModified":"2022-01-28T14:27:47+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocitoaferesis-en-2017-puesta-al-dia-spanish\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/6627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=6627"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=6627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}